Preliminary Clinical Experience with Ticarcillin (BRL 2288) in 101 Patients Treated for Severe Respiratory Infections
作者:
A. Pines,
G. Khaja,
H. Raafat,
K.S. Sreedharan,
期刊:
Chemotherapy
(Karger Available online 1974)
卷期:
Volume 20,
issue 1
页码: 39-44
ISSN:0009-3157
年代: 1974
DOI:10.1159/000221789
出版商: S. Karger AG
关键词: Ticarcillin;Chronic bronchitis;Bronchiectasis;Secondary infected carcinoma;Purulent exacerbations;Relapse time;Toxicity
数据来源: Karger
摘要:
Ticarcillin is a promising new penicillin with certain advantages. It was very effective in five out of six patients with Pseudomonas infection and in 95 patients with purulent exacerbations of chronic bronchitis or bronchiectasis, or secondary infected carcinoma, who had failed to respond to other antibiotics. Toxicity was minimal.
点击下载:
PDF
(1416KB)
返 回